Rachel Leheny

Rachel Anne Leheny is the founder of Valence Life Sciences LLC, founded in 2012, serving as Founding Managing Director.
Dr. Leheny was the founder of Caxton Advantage Venture Partners, founded in 2006, serving as Managing Director.
Current jobs include Chief Executive Officer & Director at CalciMedica, Inc. since 2019; Director & Manager at Valence Investments SPV IV LLC; Director at DalCor Pharmaceuticals Canada, Inc.; and Member at Advantage Life Sciences Partners LLC.
Former jobs include Chief Executive Officer & Director at CalciMedica Subsidiary, Inc.; Managing Director at Hambrecht & Quist Group from 1993 to 1998; Director at Corthera, Inc.; Independent Director at Anthera Pharmaceuticals, Inc. in 2011; Senior Vice President at Lehman Brothers, Inc. from 2000 to 2002; Faculty Member at the University of California, Berkeley; Principal at Caxton Health Holdings LLC; Executive Vice President at UBS Warburg, Inc.; and Chief Operating Officer at The Clearity Foundation from 2015 to 2017.
Education includes a doctorate from The Trustees of Columbia University in The City of New York, conferred in 1991, and undergraduate studies at Harvard College.